Under the light microscope a wet preparation of platelets usually shows them to be predominantly disc-shaped but with some pleomorphism; electron microscope pictures of platelets fixed in vivo suggest that they are normally flattened discs with a smooth outline. It is reported (Bull and Zucker, 1965 ) that platelets become more spherical and increase in volume when adenosine diphosphate sodium salt (A.D.P.) is added but that no change occurs when adrenaline is added. A technique to be described permits a second-by-second evaluation of the mean platelet shape. The change in shape in a number of situations will be reported and discussed. Preliminary findings have already been reported (O'Brien, 1965 (O'Brien, , 1966 .
REAGENTS
Adenosine diphosphate sodium salt (A.D.P.), adenosine, and p-tosyl arginine methylester (T.A.M.E.) were obtained from Sigma Chemicals, 5-hydroxytryptamine creatinine sulphate (5-HT) from Roche Products Ltd., and adrenaline acid tartrate from British Drug Houses; human thrombin from the Lister Institute, and sodium monoiodo-acetate (M.I.A.) from L. Light and Co. Ltd. These were made up in barbitone saline, buffered to pH 7 35. The adrenaline solution was made up daily from the powder. Human tendon was ground up with sand and saline, and the liquid decanted and centrifuged slowly. This saline extract will be referred to as collagen.
METHOD
The method is based on the well-known finding that Received for publication 14 October 1965. asymmetrical particles (e.g., bacilli) shaken in a test tube can be seen to 'swirl' because they become orientated across a velocity gradient. Symmetrical particles (e.g., cocci) cannot become orientated and on shaking no swirl is seen.
Two ml. citrated human platelet-rich plasma is placed in a small cuvette which is partially immersed in a Perspex water bath on the stage of a modified E.E.L. titrometer. The plasma is stirred at constant speed by a special constant-speed motor with a plastic-coated magnet in the cuvette. The temperature of the water bath is kept constant by circulating water through it from a large reservoir at the appropriate temperature, usually 37°C. unless otherwise stated. On stirring the platelet-rich plasma, swirling is seen and the light transmitted to the photocell fluctuates rapidly. The signal from the photocell is made to activate a ten millivolt pen recorder with a rapid response time and chart speed 2 in. per minute. This rapid fluctuation will be called the amplitude of the tracing. When platelets aggregate, more light reaches the photocell and the mean level of the tracing goes down. However, when sizable aggregates form, these interfere with the light path and cause rapid fluctuations. In the early stages of aggregation this does not occur and any change in the amplitude of the tracings at this time reflects a change in the degree of average symmetry or asymmetry of the platelets.
RESULTS
BENADRYL If citrated or heparinized platelet-rich plasma is stirred and 0-1 ml. of cocaine 3 mg./ml. (Fig. 11) M x 10-5 is added to 2 ml. of platelet-rich plasma, the addition causes an immediate slight increase in transmission by simple dilution which is reflected in a displacement downwards of the mean level of the tracing (Fig. 1) . The amplitude then decreases rapidly and at the precise moment it reaches its minimum the mean level of the tracing starts going down which indicates that aggregation is beginning. Thus, the change in shape from asymmetrical to a more symmetrical form occurs in the two or three seconds before the platelets become sticky enough to begin sticking together. If 0-1 ml. adenosine or adenosine monophosphate (A.M.P.) M x 10-2 is added to platelet-rich plasma it has no effect on the amplitude; if A.D.P. is then added, neither the change in amplitude nor aggregation occur (Fig. 2) . If weaker A.M.P. or adenosine (e.g., M x 10-5) is added before the A.D.P. partial aggregation subsequently occurs and also some diminution of the amplitude. No strength inhibits aggregation without a parallel inhibition of the amplitude.
Sodium monoiodo-acetate, 0-1 ml. of M x 10-2, incubated at 37°C. with 2 ml. of platelet-rich plasma, completely inhibits both the decrease in amplitude and aggregation when A.D.P. is added (Fig. 3) but by incubating the platelet-rich plasma with monoiodo-acetate for a shorter time, or using a weaker solution or stronger A.D.P. it was repeatedly shown that an apparently full decrease in amplitude could be obtained with an almost complete inhibition of aggregation. The addition of 0-1 ml. of E.D.T.A. over a concentration range from 2 to 10% added to citrated or heparinized platelet-rich plasma produces no change in amplitude. If A.D.P. is now added, the amplitude decreases normally (Fig. 4) but aggregation is inhibited. P-tosyl arginine methylester over a considerable range of strengths and even at a concentration of 5M x 10-1 (initial concentration) itself produces no change in amplitude. When A.D.P. M x 10-5 was added the amplitude decreased normally but aggregation was totally inhibited (Fig. 5) . Thus no strength of p-tosyl arginine methylester studied prevented the decrease in amplitude. The addition of thrombin, 0 1 ml. of 1-25 units/ml., causes no change in amplitude for up to 10 seconds, then the amplitude decreases and aggregation begins (Fig. 13) . If p-tosyl arginine methylester, 0-1 ml. M x 10-2, is added to platelet-rich plasma and then thrombin, no diminution in amplitude, no aggregation, and no clotting occur, even if very strong thrombin is used: otherwise the effect of the inhibitors on aggregation and amplitude were identical with their effect on subsequently adding adenosine diphosphate.
When 0 1 ml. collagen is added to platelet-rich plasma the opacity of the collagen is so great that it increases the optical density of the plasma and the tracing is displaced upwards (Fig. 6) : after a delay of about 60 seconds the amplitude, hitherto unaffected by the addition, decreases rapidly and is immediately followed by aggregation. As with A.D.P., the prior addition of adenosine or A.M.P. inhibits both the decrease in amplitude and aggregation (Fig. 7) . Monoiodo-acetate, 0-1 ml. of M x 10-1, prevents the decrease in amplitude and inhibits aggregation (Fig. 8) . Unlike the situation with A.D.P., any strength of monoiodo-acetate that inhibits aggregation also inhibits the decrease in amplitude. Both E.D.T.A. (Fig. 9 ) and p-tosyl arginine methylester (Fig. 10) inhibit aggregation but the decrease in amplitude occurs normally. ADRENALINE On adding adrenaline, M x 10-2, aggregation is rapid, giving a steep slope on the tracing, and it is difficult to study any change in amplitude. When adrenaline, 0-1 ml. M x 10-5, iS added no change in amplitude occurs but the platelets aggregate (Fig. 14) . The prior addition of p-tosyl arginine methylester inhibits aggregation, and the absence of change in amplitude is clear (Fig. 15) . TEMPERATURE Citrated platelet-rich plasma prepared at room temperature was warmed to 37°C. for 5 min. and the amplitude recorded. The temperature was then lowered stepwise and immediately after equilibration the plasma was again stirred and the amplitude recorded (Fig. 16) Probably the only attribute of the platelet that influences the amplitude of the tracings is its shape. Bull and Zucker (1965) have shown that on adding A.D.P. not only is the platelet shape changed but the platelet volume increases by about 20%. The changes in shape and in volume presumably occur simultaneously and indicate a radical change in the membrane permeability reflected in the uptake of water. There is no information available whether water was taken in in all circumstances in which a decrease in amplitude was recorded above, but this seems probable.
Following the addition of A.D.P. or 5-HT the change in shape immediately precedes the development of stickiness; and with thrombin and collagen, these two phenomena always occur sequentially after the considerable delay following the addition of the aggregating agent. If the effect of adrenaline (aggregation and no change in amplitude) is ignored for the moment, it is possible to suggest that the change in shape is a prerequisite of the development of 'stickiness' and that the two phenomena are closely linked since one is always immediately followed by the other. In Salzman and Chambers (1964) reported that p-tosyl arginine methylester inhibits A.D.P.-induced aggregation competitively which suggests that it is interfering with an enzymatic process concerned with the development of stickiness. However, it has no effect on the change in shape and must act after this process is complete. Adenosine and A.M.P. inhibit both aggregation and the change in shape and are competitive and must act earlier in the chain of events or at a site common to both change in shape and aggregation. If it is assumed that 5-HT and thrombin and collagen eventually all cause stickiness and the change in shape by activating an intrinsic A.D.P. system then it is possible to construct a hypothetical diagram (Fig. 17) The arguments above have ignored the action of adrenaline and noradrenaline that produce stickiness with no change in shape or volume (Bull and Zucker, 1965) . The kinetics of adrenaline-induced aggregation have important differences from those resulting from the other aggregating agents (O'Brien, 1964) . Perhaps the catecholamines cause platelets to stick together through binding forces completely different from those produced by the other aggregating agents, in which case the suggestions of Fig. 17 may stand. If, however, the kind of stickiness induced is the same for all aggregating agents, then clearly stickiness does not always follow the change in shape with its implication of causality. Figure 17 can, however, be redrawn with the development of stickiness, and the change in shape, being independent results of the intrinsic A.D.P. system and sites of action of the inhibitors, can still be suggested compatible with the reported observations (Fig. 18) .
Platelets are more rounded at low temperatures and are most asymmetrical at 29 to 40°C. The rounded form is the configuration requiring least energy to maintain and oval flattened discs, the usual shape in the body, will require more energy. This energy is almost certainly derived from enzymatic metabolism in vivo and it will decrease at low temperature. The same explanation may apply to the change in shape above 43°C.
